Class IOngoingD-0388-2026
Drug recall · March 11, 2026
SILINTAN 25/pills recall
Why: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Lots / codes
All lots within expiry
- Quantity
- N/A
- Company
- ANTHONY TRINH, 123Herbals LLC, Rosemead, CA
- Distribution
- USA nationwide
- Initiated
- October 20, 2025 · Voluntary: Firm initiated
- Classified
- March 13, 2026
- Reported
- March 11, 2026
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.